MITO goes private @$0.375/sh—a 34% premium to the “unaffected” 6/24/22 close—but less than half the price MITO was trading at in early 2022: https://finance.yahoo.com/news/stealth-biotherapeutics-corp-enters-definitive-123000940.html The nominal deal value is $27M.